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Abstract
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transmembrane and extracellular cues, one of which is collagen XIII, regulate the formation and
function of the neuromuscular synapse, and their absence results in myasthenia. We show that
the phenotypical changes in collagen XIII knock-out mice are milder than symptoms in human
patients, but the Col13a1 -/- mice recapitulate major muscle findings of congenital myasthenic
syndrome type 19 and serve as a disease model. In the lack of collagen XIII neuromuscular
synapses do not reach full size, alignment, complexity and function resulting in reduced muscle
strength. Collagen XIII is particularly important for the preterminal integrity, and when absent,
destabilization of the motor nerves results in muscle regeneration and in atrophy especially in
the case of slow muscle fibers. Collagen XIII was found to affect synaptic integrity through
binding  the  ColQ  tail  of  acetylcholine  esterase.  Although  collagen  XIII  is  a  muscle-bound
transmembrane molecule, it also undergoes ectodomain shedding to become a synaptic basal
lamina component. We investigated the two forms' roles by novel Col13a1 tm/tm mice in which
ectodomain  shedding  is  impaired.  While  postsynaptic  maturation,  terminal  branching  and
neurotransmission was exaggerated in the Col13a1 tm/tm mice, the transmembrane form's
presence  sufficed  to  prevent  defects  in  transsynaptic  adhesion,  Schwann  cell
invagination/retraction,  vesicle  accumulation  and  acetylcholine  receptor  clustering  and
acetylcholinesterase dispersion seen in the Col13a1 -/- mice, pointing to the transmembrane
form  as  the  major  conductor  of  collagen  XIII  effects.  Altogether,  collagen  XIII  secures
postsynaptic, synaptic and presynaptic integrity, and it is required for gaining and maintaining
normal size, complexity and functional capacity of the neuromuscular synapse.
http://dx.doi.org/10.1093/hmg/ddx101
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